References
- 12. Sethi NJ, Safi S, Korang SK, et al. Antibiotics for secondary prevention of coronary heart disease. Cochrane Database of Systematic Reviews. 2017;7:CD003610. doi: 10.1002/14651858. CD003610.pub3.10.1002/14651858.CD003610.pub3
- 13. World Health Organization. Cardiovascular Diseases fact sheet (updated May 2017). Available at: http://www.who.int/mediacentre/factsheets/fs317/en/
- 14. Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins. Curr Atheroscler Rep. 2017;19:57. doi: 10.1007/s11883-017-0696-4.10.1007/s11883-017-0696-4
- 15. Theodora Benedek. The Link between Periodontal Disease, Inflammation and Atherosclerosis – an Interdisciplinary Approach. Journal of Interdisciplinary Medicine. 2017;2(S1):11-16. doi: 1.0.1515/jim-2017-0016.10.1515/jim-2017-0016
- 16. Lawson JS. Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery Disease. Front Cardiovasc Med. 2016;3:30. doi:10.3389/fcvm.2016.00030.10.3389/fcvm.2016.00030
- 17. B Kalra DK, Heo R, Valenti V, Nakazato R, Min JK. Role of Computed Tomography for Diagnosis and Risk Stratification of Patients with Suspected or Known Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2014;34:1144-1154. doi: 10.1161/ATVBAHA.113.302074.10.1161/ATVBAHA.113.302074
- 18. Fatkhullina AR, Peshkova IO, Koltsova EK. The Role of Cytokines in the Development of Atherosclerosis. Biochemistry (Mosc). 2016;81:1358-1370. doi: 10.1134/S0006297916110134.10.1134/S0006297916110134
- 19. Hansen GM, Egeberg A, Holmstrup P, Hansen PR. Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (From a Danish Nationwide Cohort Study). Am J Cardiol. 2016;118:489-493. doi: 10.1016/j.amjcard.2016.05.036.10.1016/j.amjcard.2016.05.036
- 20. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11:72-80.
- 21. Gualtero DF, Lafaurie GI, Fontanilla MR. Two-dimensional (2D) and three-dimensional (3D) models for studying atherosclerosis pathogenesis induced by periodontopathogenic microorganisms. Mol Oral Microbiol. 2017. doi: 10.1111/omi.12201.10.1111/omi.12201
- 22. Martu S, Nicolaiciuc O, Solomon S, et al. The Evaluation of the C Reactive Protein Levels in the Context of the Periodontal Pathogens Presence in Cardiovascular Risk Patients. Revista de Chimie. 2017;68:605-607.10.37358/RC.17.5.5616
- 23. Fonseca FAH, de Oliveira Izar MC. High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities”. Clinics (Sao Paulo). 2016;71:235-242. doi: 10.6061/clinics/2016(04)11.10.6061/clinics/2016(04)11
- 24. Assadpour Piranfar M. The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis. Int Cardiovasc Res J. 2014;8:6-8.
- 25. van Soesta G, Marcub L, Boumac BE, Regardet E. Intravascular imaging for characterization of coronary atherosclerosis. Current Opinion in Biomedical Engineering. 2017;3:1-12. doi. org/10.1016/j.cobme.2017.07.001.10.1016/j.cobme.2017.07.001
- 26. Libby P, Theroux P. Pathophysiology of Coronary Artery Disease. Circulation. 2005;111:3481-3488. doi: 10.1161/CIRCULATIONAHA.105.537878.10.1161/CIRCULATIONAHA.105.53787815983262